- Home
- EGF vs CODX Comparison
EGF vs CODX Comparison
Compare EGF & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EGF
- CODX
- Stock Information
- Founded
- EGF 2006
- CODX 2013
- Country
- EGF United States
- CODX United States
- Employees
- EGF N/A
- CODX N/A
- Industry
- EGF Trusts Except Educational Religious and Charitable
- CODX Medical/Dental Instruments
- Sector
- EGF Finance
- CODX Health Care
- Exchange
- EGF Nasdaq
- CODX Nasdaq
- Market Cap
- EGF N/A
- CODX 39.3M
- IPO Year
- EGF N/A
- CODX 2017
- Fundamental
- Price
- EGF $9.88
- CODX $1.28
- Analyst Decision
- EGF
- CODX Hold
- Analyst Count
- EGF 0
- CODX 1
- Target Price
- EGF N/A
- CODX $1.50
- AVG Volume (30 Days)
- EGF 9.7K
- CODX 87.5K
- Earning Date
- EGF 01-01-0001
- CODX 11-07-2024
- Dividend Yield
- EGF 5.17%
- CODX N/A
- EPS Growth
- EGF N/A
- CODX N/A
- EPS
- EGF N/A
- CODX N/A
- Revenue
- EGF N/A
- CODX $9,136,969.00
- Revenue This Year
- EGF N/A
- CODX N/A
- Revenue Next Year
- EGF N/A
- CODX N/A
- P/E Ratio
- EGF N/A
- CODX N/A
- Revenue Growth
- EGF N/A
- CODX 25.24
- 52 Week Low
- EGF $9.02
- CODX $1.00
- 52 Week High
- EGF $10.47
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- EGF 45.42
- CODX 50.73
- Support Level
- EGF $9.80
- CODX $1.18
- Resistance Level
- EGF $9.99
- CODX $1.35
- Average True Range (ATR)
- EGF 0.07
- CODX 0.08
- MACD
- EGF -0.02
- CODX 0.00
- Stochastic Oscillator
- EGF 45.00
- CODX 45.45
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.